Berlin, Germany

Hans-Peter Muhn


 

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Hans-Peter Muhn in Berlin

Introduction

Hans-Peter Muhn, an accomplished inventor based in Berlin, Germany, is recognized for his innovative contributions to the field of medicinal chemistry. With a total of 14 patents to his name, he has developed several novel compounds that hold promise for medical applications, particularly in hormonal therapies.

Latest Patents

Among his latest patents are the development of 19-nor-steroid derivatives featuring a 15α,16α-methylene group and a saturated 17,17-spirolactone ring. These compounds have been shown to possess progestational efficacy. The general chemical formula for these compounds includes various configurations of substituents that enhance their therapeutic potential.

Another significant patent focuses on 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivatives. This invention details their use in producing medicinal products aimed at oral contraception and treating pre-, peri-, and postmenopausal complaints. The derivatives have demonstrated progestational effects and, in certain cases, additional properties such as antimineralocorticoid and neutral to slightly androgenic actions.

Career Highlights

Hans-Peter Muhn has built his career at notable companies, including Schering Aktiengesellschaft and Bayer Intellectual Property GmbH. His work at these institutions has been pivotal in advancing pharmaceutical innovations and enhancing the therapeutic landscape.

Collaborations

Throughout his career, Muhn has collaborated with esteemed scientists such as Joachim Kuhnke and Rolf Bohlmann. These collaborations have likely facilitated the exchange of ideas and expertise, leading to impactful advancements in steroid chemistry.

Conclusion

Hans-Peter Muhn's contributions to the field through his patents and collaborative efforts demonstrate his commitment to innovation in medicinal chemistry. His work not only enriches scientific understanding but also paves the way for new therapeutic options in hormonal treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…